Low-concentration bimatoprost 0.01% and timolol 0.1% eye gel versus bimatoprost 0.03% and timolol 0.5% eye drops in open-angle glaucoma or ocular hypertension: a phase III randomised study
Low-concentration BTFC eye gel can be considered as a safe and effective treatment in the therapeutic management of glaucoma and OHT.
Authors
- Piotr Gościniewicz
- Ingeborg Stalmans (ORCID: https://orcid.org/0000-0001-7507-4512)
- M. Francesca Cordeiro (ORCID: https://orcid.org/0000-0001-8663-6525)
- Francesco Oddone (ORCID: https://orcid.org/0000-0002-2504-0004)
- Dariusz Rokicki (ORCID: https://orcid.org/0000-0002-9736-2838)
- Елена Мермеклиева (ORCID: https://orcid.org/0000-0003-1134-520X)
- Sylvie Nisslé
Institutions
- Ofcom (GB)
- Medical University of Sofia (BG)
- Fondazione G.B. Bietti (IT)
- NIHR Imperial Biomedical Research Centre (GB)
- Neuroelectronics Research Flanders (BE)
- WSB University (PL)
- Thea (France) (FR)
- University College London (GB)
- Imperial College London (GB)
- Sofia University "St. Kliment Ohridski" (BG)
- KU Leuven (BE)
Publication Details
- Journal
- British Journal of Ophthalmology
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1136/bjo-2025-327555
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00